☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Port Delivery System
Roche Report the US FDA's Acceptance of BLA for Port Delivery System with Ranibizumab to Treat Neovascular Age-Related Macular Deg...
June 24, 2021
Genentech Reports Results of Port Delivery System with Ranibizumab in P-III Archway Study for Neovascular Age-Related Macular Dege...
July 23, 2020
Roche Reports Results of Port Delivery System with Ranibizumab in P-III Archway Study for Neovascular Age-Related Macular Degenera...
May 27, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.